Core Scientific (CORZ) Accounts Payables (2021 - 2026)

Core Scientific (CORZ) has 6 years of Accounts Payables data on file, last reported at $218.9 million in Q1 2026.

• Quarterly Accounts Payables rose 3358.55% year-over-year to $218.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $218.9 million (up 3358.55% YoY) and the FY2025 annual result came in at $126.1 million, up 554.59% from the prior year.
• Accounts Payables rose to $218.9 million in Q1 2026 per CORZ's latest filing, from $126.1 million in the prior quarter.
• The five-year high for Accounts Payables was $218.9 million in Q1 2026, with the low at $6.3 million in Q1 2025.
• Average Accounts Payables over 5 years is $75.2 million, with a median of $45.5 million recorded in 2023.
• Year-over-year, Accounts Payables soared 18028.55% in 2022 and tumbled 87.55% in 2024.
• Core Scientific's Accounts Payables stood at $53.6 million in 2022, then surged by 188.49% to $154.8 million in 2023, then plunged by 87.55% to $19.3 million in 2024, then surged by 554.59% to $126.1 million in 2025, then soared by 73.55% to $218.9 million in 2026.
• Business Quant data shows CORZ's Accounts Payables at $218.9 million in Q1 2026, $126.1 million in Q4 2025, and $212.2 million in Q3 2025.